ACAN is positioned for a dramatic 2018. $ACAN
They have invested millions of dollars and over two years in the design, processing and preparing for construction of their highly ambitious flagship Massachusetts Medical Cannabis (MMCC)—a giant 1 million square foot cannabis production and processing plant 47 miles south of Boston.
This MMCC was designed by a team of scientists and engineers to become, when completed, the largest, most energy efficient and technologically advanced cannabis facility in the US. It’s all approved for construction and the first phase is pre leased to one of the 15 Massachusetts licensees.
With Massachusetts now preparing to launch the rollout of full adult use cannabis on July 1 (less than five months) ACAN is in the perfect place with the perfect development. There will be lines around the block at every dispensary, shortages of cannabis and high prices.
Experts unanimously call Massachusetts one of the best new emerging opportunities for cannabis and predict it will become a $1 Billion a year market as the only state with legal cannabis in the entire Northeast for several years.
A billion dollar market will require over 2 million SF of cultivation and the entire state has less than 500,000 SF.
The publicity ACAN will receive when they start construction (which is reportedly very close) will be substantial and the financial impact
from MMCC will likely be significant
for ACAN shareholders.
And ACAN has only about 20 million shares outstanding unlike many other publicly traded cannabis companies that have 300 million to a billion shares.
There is a lot to get excited about if you are an ACAN shareholder, IMO. $ACAN
